4-(3,5-BIS-(2-HYDROXY-PHENYL)-(1, 2,4)TRIAZOL-1-YL)-BENZOIC ACID DERIVATIVES FOR TREATING AN EXCESS OF METAL IN THE BODY

Details for Australian Patent Application No. 2002351843 (hide)

Owner NOVARTIS AG

Inventors WALDMEIER, Felix; LATTMAN, Rene

Pub. Number AU-A-2002351843

PCT Number PCT/EP02/12342

PCT Pub. Number WO2003/039541

Priority 0126618.8 06.11.01 GB

Filing date 5 November 2002

Wipo publication date 19 May 2003

International Classifications

A61K 031/4196 - 1,2,4-Triazoles

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61P 039/04 General protective or antinoxious agents

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 0126618.8 06.11.01 GB

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002351843

22 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351844-Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination

2002351842-BEHELTER ZUM TRANSPORT VON GETERN